$0.37
6.97% today
Nasdaq, Apr 04, 08:45 pm CET
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Generation Bio Co Stock price

$0.40
-0.14 25.99% 1M
-1.98 83.30% 6M
-0.66 62.50% YTD
-3.72 90.35% 1Y
-8.35 95.46% 3Y
-24.29 98.39% 5Y
-24.29 98.39% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
+0.03 7.37%
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Key metrics

Market capitalization $26.64m
Enterprise Value $-65.02m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.71
EV/Sales (TTM) EV/Sales -3.27
P/S ratio (TTM) P/S ratio 1.34
P/B ratio (TTM) P/B ratio 0.31
Revenue growth (TTM) Revenue growth 236.92%
Revenue (TTM) Revenue $19.89m
EBIT (operating result TTM) EBIT $-78.33m
Free Cash Flow (TTM) Free Cash Flow $-90.96m
Cash position $185.22m
EPS (TTM) EPS $-1.98
P/E forward negative
P/S forward 4.74
EV/Sales forward negative
Short interest 4.18%
Show more

Is Generation Bio Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Generation Bio Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Generation Bio Co forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Generation Bio Co forecast:

Buy
67%
Hold
33%

Financial data from Generation Bio Co

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20 20
237% 237%
100%
- Direct Costs 4.93 4.93
6% 6%
25%
15 15
2,238% 2,238%
75%
- Selling and Administrative Expenses 32 32
26% 26%
162%
- Research and Development Expense 56 56
33% 33%
282%
-73 -73
42% 42%
-369%
- Depreciation and Amortization 4.93 4.93
6% 6%
25%
EBIT (Operating Income) EBIT -78 -78
40% 40%
-394%
Net Profit -132 -132
4% 4%
-662%

In millions USD.

Don't miss a Thing! We will send you all news about Generation Bio Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Generation Bio Co Stock News

Neutral
GlobeNewsWire
2 days ago
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th ...
Neutral
GlobeNewsWire
22 days ago
-  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases
Neutral
GlobeNewsWire
about one month ago
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. ET in Boston.
More Generation Bio Co News

Company Profile

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Head office United States
CEO Cameron McDonough
Employees 115
Founded 2016
Website www.generationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today